Open Access

Targeting Lp(a) in CV risk reduction: where are we now?

Topic: Lipid-Lowering Agents
Organised by PACE-CME - Supported by an unrestricted educational grant from Novartis, Sanofi, New Amsterdam & other sponsors

Congress Session

About the speaker

Doctor Pia Kamstrup

Copenhagen University Hospital - Herlev Gentofte, Herlev (Denmark)
3 presentations
0 follower

3 more presentations in this session

Lp(a) as independent causal risk factor: why should we focus on testing?

Speaker: Professor F. Kronenberg (Innsbruck, AT)

Thumbnail

Targeting Lp(a): therapeutic insights and novel developments.

Speaker: Professor E. Stroes (Amsterdam, NL)

Thumbnail

Discussion.

Speaker: Professor E. Stroes (Amsterdam, NL) Doctor P. Kamstrup (Herlev, DK) Professor F. Kronenberg (Innsbruck, AT)

Thumbnail

Access the full session

Lp(a): from causality to therapy

Speakers: Doctor P. Kamstrup, Professor F. Kronenberg, Professor E. Stroes, Professor E. Stroes, Doctor P. Kamstrup...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk